Corneal Disease Clinical Trial
Official title:
Corneal Densitometry Changes With Adenoviral Keratoconjunctivitis Sub Epithelial Infiltrates
| NCT number | NCT04267991 |
| Other study ID # | Hamaky5 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | April 1, 2018 |
| Est. completion date | April 15, 2020 |
| Verified date | May 2020 |
| Source | Benha University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Adenoviral Sub epithelial infiltrates (SEI) affect ocular function.They lead to reduced vision, photophobia, glare, halos, and foreign body sensation.
| Status | Completed |
| Enrollment | 63 |
| Est. completion date | April 15, 2020 |
| Est. primary completion date | April 1, 2020 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - adenoviral SEI Exclusion Criteria: - Other corneal diseases |
| Country | Name | City | State |
|---|---|---|---|
| United Arab Emirates | INMC | Abu Dhabi |
| Lead Sponsor | Collaborator |
|---|---|
| Benha University |
United Arab Emirates,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | changes of corneal densitometry | Sub epithelial infiltrates was examined with the densitometry programme of the Pentacam (Fa. Oculus,Weimar, Germany) | 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05114928 -
Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.
|
||
| Recruiting |
NCT06160960 -
Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome
|
||
| Completed |
NCT00357435 -
Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
|
||
| Completed |
NCT04484402 -
Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05581875 -
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06101017 -
Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
|
||
| Withdrawn |
NCT03421548 -
Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
|
N/A | |
| Withdrawn |
NCT05700864 -
NGF Treatment for Patients With Neuropathic Corneal Pain
|
Phase 1 | |
| Enrolling by invitation |
NCT05758753 -
QST for Corneal Nerve Function
|
N/A | |
| Terminated |
NCT00001310 -
Tissue Studies of Human Eye Diseases
|
||
| Completed |
NCT02386774 -
Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa
|
N/A | |
| Recruiting |
NCT05694247 -
Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness
|
N/A | |
| Not yet recruiting |
NCT06294015 -
Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.
|
Phase 4 | |
| Completed |
NCT00654888 -
Automated Lamellar Keratectomy in Symptomatic Patients With Bullous Keratopathy
|
N/A | |
| Recruiting |
NCT04251143 -
Dresden Corneal Disease and Treatment Study
|
||
| Withdrawn |
NCT02374723 -
Evaluation of Biosynthetic Constructs to Replace Donor Corneas
|
Phase 1 | |
| Completed |
NCT01384487 -
Nidek RS3000 Comparative Study
|
N/A | |
| Completed |
NCT00804505 -
Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study
|
N/A | |
| Completed |
NCT04475900 -
Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
|
||
| Recruiting |
NCT05573802 -
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
|
Phase 1/Phase 2 |